RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
-0.81%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$3.79B
AUM Growth
+$3.79B
(+12%)
Cap. Flow
+$467M
Cap. Flow
% of AUM
12.33%
Top 10 Holdings %
Top 10 Hldgs %
44.71%
Holding
74
New
6
Increased
31
Reduced
8
Closed
7
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$65.8M |
| 2 |
Alight
ALIT
|
$62.2M |
| 3 |
Pediatrix Medical
MD
|
$54.7M |
| 4 |
Avis
CAR
|
$49.7M |
| 5 |
Opko Health
OPK
|
$49.4M |
Top Sells
| 1 |
iShares Bitcoin Trust
IBIT
|
$69.7M |
| 2 |
Atmus Filtration Technologies
ATMU
|
$36.5M |
| 3 |
Par Pacific Holdings
PARR
|
$28.6M |
| 4 |
PLYA
Playa Hotels & Resorts
PLYA
|
$26.2M |
| 5 |
ANI Pharmaceuticals
ANIP
|
$22.6M |
Sector Composition
| 1 | Healthcare | 49.8% |
| 2 | Technology | 9.14% |
| 3 | Industrials | 7.83% |
| 4 | Financials | 7.41% |
| 5 | Utilities | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $281M | 7.35% | 17,261,741 -407,847 | -2% | -$6.63M |
|
2
Roivant Sciences
ROIV
$8.15B
| $243M | 6.37% | 23,000,000 +3,000,000 | +15% | +$31.7M |
|
3
Viatris
VTRS
$12.3B
| $214M | 5.61% | 20,144,365 +1,702,272 | +9% | +$18.1M |
|
4
Golar LNG
GLNG
$4.48B
| $205M | 5.37% | 6,535,062 +28,305 | +0.4% | +$887K |
|
5
BGC Group
BGC
$4.65B
| $158M | 4.13% | 19,000,000 | – | – |
|
6
Fluor
FLR
$6.63B
| $140M | 3.67% | 3,214,521 +614,521 | +24% | +$26.8M |
|
7
Mr. Cooper
COOP
$12.1B
| $123M | 3.23% | 1,518,773 | – | – |
|
8
QuidelOrtho
QDEL
$1.95B
| $121M | 3.18% | 3,645,590 +1,245,590 | +52% | +$41.4M |
|
9
Vistra
VST
$64.1B
| $114M | 2.99% | 1,327,106 +113,108 | +9% | +$9.73M |
|
10
Liberty Global Class A
LBTYA
$4B
| $96.3M | 2.53% | 5,526,107 +1,680,756 | +44% | +$29.3M |
|
11
Heron Therapeutics
HRTX
$207M
| $93.5M | 2.45% | 26,713,503 | – | – |
|
12
Arcutis Biotherapeutics
ARQT
$1.86B
| $91.3M | 2.39% | 9,816,672 +2,306,672 | +31% | +$21.5M |
|
13
ReNew
RNW
$2.76B
| $84.3M | 2.21% | 13,506,102 +1,794,402 | +15% | +$11.2M |
|
14
Collegium Pharmaceutical
COLL
$1.22B
| $75.1M | 1.97% | 2,333,500 +499,473 | +27% | +$16.1M |
|
|
15
Avis
CAR
$5.57B
| $72.1M | 1.89% | 690,273 +475,181 | +221% | +$49.7M |
|
16
Extreme Networks
EXTR
$2.83B
| $70.7M | 1.85% | 5,254,744 +1,804,744 | +52% | +$24.3M |
|
17
Constellium
CSTM
$2.02B
| $69M | 1.81% | 3,662,895 +32,548 | +0.9% | +$614K |
|
18
Amneal Pharmaceuticals
AMRX
$3B
| $68.1M | 1.79% | 10,721,778 +1,179,830 | +12% | +$7.49M |
|
19
Mativ Holdings
MATV
$687M
| $67.8M | 1.78% | 4,000,000 | – | – |
|
|
20
Jazz Pharmaceuticals
JAZZ
$7.75B
| $65.8M | 1.73% | +616,617 | New | +$65.8M |
|
|
PTVE
21
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $64.8M | 1.7% | 5,726,583 +185,190 | +3% | +$2.1M |
|
22
Dole
DOLE
$1.4B
| $62.9M | 1.65% | 5,141,388 | – | – |
|
23
Liberty Global Class C
LBTYK
$4.07B
| $62.7M | 1.64% | 3,511,004 +1,617,711 | +85% | +$28.9M |
|
|
24
Alight
ALIT
$2.05B
| $62.2M | 1.63% | +8,423,062 | New | +$62.2M |
|
|
25
Pediatrix Medical
MD
$1.5B
| $61.5M | 1.61% | 8,150,000 +7,241,400 | +797% | +$54.7M |
|